Searchable abstracts of presentations at key conferences in endocrinology

ea0063p685 | Pituitary and Neuroendocrinology 2 | ECE2019

Copeptin in differential diagnosis in polyuric states

Pigarova Ekaterina , Dzeranova Larisa , Melnichenko Galina , Dedov Ivan

Introduction: Measurement of copeptin is proposed for use in the differential diagnosis of polyuric syndrome.Aims: To evaluate the diagnostic value of copeptin levels in patients with polyuria syndrome.Materials and methods: The study included 17 patients with central diabetes insipidus (CDI), 3 patients with nephrogenic diabetes insipidus (NDI), 7 patients with primary polydipsia (PP) and 26 control subjects. In all individuals bl...

ea0063p1117 | Pituitary and Neuroendocrinology 3 | ECE2019

Epidemiology of acromegaly in Russian Federation: evaluation of National registry-based data

Lutsenko Alexander , Przhiyalkovskaya Elena , Pigarova Ekaterina , Belaya Zhanna , Rozhinskaya Liudmila

According to state statistics service, Russia’s population in 2018 is more than 146.8 mil people. The total prevalence of acromegaly may range between 2.8 and 13.7 cases per 100,000 people and the annual incidence rates vary between 0.2 and 1.1 cases per 100,000 people (Lavrentaki A, et al. 2016). The epidemiological data for acromegaly in Russian population is lacking. The Russian hypothalamic and pituitary tumors registry was founded in 2004 and for 2018 it con...

ea0063p1136 | Reproductive Endocrinology 2 | ECE2019

Kisspeptin in regulation of menstrual function in patients with resistant hyperprolactinemia

Vorotnikova Svetlana , Pigarova Ekaterina , Dzeranova Larisa , Fedorova Natal'ya

Introduction: Patients with resistant prolactinomas have reduced fertility todue to chronic anovulation and hypoplasia of uterus and ovaries. SERM tamoxifen demonstrates a recovery of menstrual function and ovulation and reverses the hypoplasia of the uterus. The mechanism of its action in case of hyperprolactinemia is not clear yet.Aim: To study the role of kisspeptin in restoration of reproductive function in patients with prolactinomas treated by tamo...

ea0063p1140 | Reproductive Endocrinology 2 | ECE2019

Low levels of kisspeptin in patients with acromegaly

Vorotnikova Svetlana , Pigarova Ekaterina , Dzeranova Larisa , Masenko Valeriy

Introduction: Acromegaly impairs the hypothalamic-pituitary-gonadal (HPG) axis and reproductive function that causes amenorrhea and infertility. The mechanism of these disturbances is not clear. Kisspeptin and neurokinin B are very important neuropeptides regulating cyclic LH release from pituitary due to stimulation of GnRH.Aim: The purpose of this study was to assess the role of key reproductive neuropeptides in regulation of menstrual function in pati...

ea0049ep347 | Endocrine tumours and neoplasia | ECE2017

Recurrent ectopic parathyroid carcinoma

Krupinova Julia , Mokrysheva Natalia , Eremkina Anna , Pigarova Ekaterina , Mirnaya Svetlana

Background: In most cases of parathyroid carcinoma (PC) only recurrence could be a credible feature of malignancy.Clinical case: At the age of 19 years a woman was diagnosed with urolithiasis. At the age of 22 years she had a surgical resection of the neck nodule at the right site in the projection of carotid triangle. After the histological study, ectopic parathyroid tumor was misdiagnosis with paraganglioma (material is available for review). At the ag...

ea0049ep913 | Neuroendocrinology | ECE2017

Clinical case description of family with hereditary pituitary adenoma

Tarasova Tatiana , Pigarova Ekaterina , Dzeranova Larisa , Tulpakov Anatoly , Dedov Ivan

Introduction: In recent years, more attention is driven to the cause of hereditary forms of pituitary adenomas. Although for most cases causal genes are not discovered yet, AIP mutations are the most prevalent.Materials and Methods: Case descriptions, high-parallel sequencing using a gene panel (MEN1, CDKN1B, PRKAR1A, GNAS, AIP, SDHA, SDHB, SDHS, SDHD, PRKCA, CDKN2C, CDKN2A, POU1F1, PTTG2).Case description: Index ...

ea0049ep914 | Neuroendocrinology | ECE2017

Molecular and genetic basis of the disease in families with pituitary adenomas

Tarasova Tatiana , Pigarova Ekaterina , Dzeranova Larisa , Tulpakov Anatoly , Dedov Ivan

Introduction: Most of the work on the analysis of molecular genetic defects in pituitary adenomas devoted to the study of 1–2 candidate genes. The high-performance parallel sequencing is more promising.Materials and Methods: There were a total of 26 families (58 patients, 36 (62.1%) men and 22 (37.9%) women) with pituitary adenomas secretion of various types. The number of families with homogenous type was 17 (somatotropinomas 13, prolactinomas 2, c...

ea0049ep1034 | Pituitary - Clinical | ECE2017

Pregnancy outcome in women with prolactinomas exposed to dopamine agonists at early stages of gestation

Vorotnikova Svetlana , Skuridina Darya , Dzeranova Larisa , Pigarova Ekaterina , Belaya Zhanna

Introduction: Medical therapy with dopamine agonists is the best treatment for prolactinomas of any size or invasiveness and restores ovulatory cycles in 80–90% of patients. Cabergoline currently suggested nearly exclusively rather than other dopamine agonists due to its excellent tolerability and long half-life. That is why the question of safety using of this drug during pregnancy and embryo-fetal development is actual.Aim: The aim of the study is...

ea0041ep151 | Calcium and Vitamin D metabolism | ECE2016

Metabolic changes in vitamin D deficiency

Rozhinskaya Ludmila , Petrushkina Alexandra , Pigarova Ekaterina , Tarasova Tatyana , Ilyin Alexander

Introduction: The improvement of vitamin D status is necessary to overcome an impaired calcium-phosphorus metabolism and disturbances in other tissues functioning; safety of medical intervention should include analysis of metabolic changes.Material and methods: Twenty four apparently healthy volunteers 24.9±2 year were included in the study: Group 1 (11/24) with blood serum levels of 25(OH)D <10 ng/ml and Group 2 (13/24) with 25(OH)D levels 10&#...

ea0041ep267 | Clinical case reports - Pituitary/Adrenal | ECE2016

«Clinically silent» somatotropinoma

Lipatenkova Anna , Dzeranova Larisa , Pigarova Ekaterina , Grigoriev Andrey

Introduction: Somatotropinomas are typically recognized when GH excessively secretion causes acromegaly. «Silent» somatotroph adenomas (immunohistochemical evidence of GH excess without biochemical or clinical evidence) and «clinically silent» somatotroph adenomas (immunohistochemical and biochemical evidence without clinical evidence) have occasionally been reported. The relative frequency of each presentation is unknown.<p class="abst...